Last reviewed · How we verify

NCT06886633

The Effect of Breathing Exercise and Pressurized Cold Application on Pain and Anxiety During Sharp Debridement

ENROLLING BY INVITATION NA Last updated 20 March 2025
What this trial tests

NA trial testing Breathing exercise in Diabetic Foot Ulcer in 78 participants. Enrolling by invitation.

Timeline
1 March 2025
Primary endpoint
15 October 2025
30 October 2025

Quick facts

Lead sponsorHarran University
PhaseNA
StatusENROLLING BY INVITATION
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposehealth services research
Enrollment78
Start date1 March 2025
Primary completion15 October 2025
Estimated completion30 October 2025
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Harran University

Who can join

Eligibility, any sex, with Diabetic Foot Ulcer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In our planned study, it is envisaged that patients who receive breathing exercises and pressurized cold application will experience a decrease in the level of pain they feel during the debridement process, a decrease in their anxiety levels, and an improvement in their vital signs, and that these study findings will constitute an important data source to reduce the pain and anxiety that occurs during the debridement process.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Breathing exercise

Trials testing the same drug.

Other recruiting trials for Diabetic Foot Ulcer

Currently open trials in the same condition.

Other Harran University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06886633.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing